Showing results (1-10 of 323) with videos related to
Sort By:
Pageof 33
The Prostate|June 21, 2011
Contemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: clinical factors associated with PSA response and disease progressionDaniel Keizman, Peng Huang, Michael A Carducci, et al.Cancer|October 1, 2011
Changes in PSA kinetics predict metastasis- free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents: combined analysis of 4 phase II trialsEmmanuel S Antonarakis, Marianna L Zahurak, Jianqing Lin, et al.European Journal of Cancer (Oxford, England : 1990)|October 25, 2011
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinomaDaniel Keizman, Maya Ish-Shalom, Peng Huang, et al.European Journal of Cancer (Oxford, England : 1990)|May 24, 2011
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examinationDaniel Keizman, Peng Huang, Mario A Eisenberger, et al.The Prostate|December 17, 2013
Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxelAvivit Peer, Maya Gottfried, Victoria Sinibaldi, et al.The Prostate|March 25, 2011
The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen deprivationDaniel Keizman, Peng Huang, Emmanuel S Antonarakis, et al.Current Opinion in Supportive and Palliative Care|July 9, 2010
Is there a role for chemotherapy in nonmetastatic prostate cancer?Daniel Keizman, Mario EisenbergerHarefuah|February 2, 2013
[Metastatic hormone refractory prostate cancer: new treatment horizon]Daniel Keizman, Natalie Maimon, Maya GottfriedAmerican Journal of Clinical Oncology|July 10, 2012
Metastatic hormone refractory prostate cancer: recent advances in standard treatment paradigm, and future directionsDaniel Keizman, Natalie Maimon, Maya GottfriedPageof 33